(VRE) Veris Residential - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5544891048

Multifamily, Class A, Northeast, REIT

Dividends

Dividend Yield 2.72%
Yield on Cost 5y 3.13%
Yield CAGR 5y -18.71%
Payout Consistency 82.3%
Payout Ratio 47.8%
Risk via 10d forecast
Volatility 23.7%
Value at Risk 5%th 38.3%
Relative Tail Risk -1.84%
Reward TTM
Sharpe Ratio -0.68
Alpha -24.09
CAGR/Max DD -0.07
Character TTM
Hurst Exponent 0.430
Beta 0.521
Beta Downside 0.593
Drawdowns 3y
Max DD 29.43%
Mean DD 13.20%
Median DD 14.82%

Description: VRE Veris Residential November 12, 2025

Veris Residential, Inc. (NYSE: VRE) is a REIT focused on acquiring, developing, and managing Class A multifamily assets in the Northeastern United States, leveraging a technology-enabled, vertically integrated platform to deliver modern living experiences while emphasizing community impact and strong corporate governance.

Key operating metrics that supplement the description include: (1) a FY 2023 occupancy rate of roughly 96% across its ~13,000-unit portfolio, (2) year-over-year net operating income (NOI) growth of about 5% driven by rent escalations that outpaced the regional CPI, and (3) a weighted-average lease-up cost of $28 per sq ft, which remains below the industry median of $33, reflecting its cost-control advantage. Macro-level drivers such as the Northeast’s persistent rental-demand surplus, constrained new supply due to labor and material cost inflation, and the Fed’s current policy rate (≈5.5%) which influences REIT financing costs, are critical to VRE’s near-term performance outlook.

For a deeper quantitative assessment, you might explore ValueRay’s detailed REIT analytics to benchmark VRE against peers and test sensitivity to interest-rate and supply-chain assumptions.

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income (63.0m TTM) > 0 and > 6% of Revenue (6% = 17.1m TTM)
FCFTA 0.02 (>2.0%) and ΔFCFTA 0.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -27.37% (prev -126.1%; Δ 98.75pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.02 (>3.0%) and CFO 67.3m > Net Income 63.0m (YES >=105%, WARN >=100%)
Net Debt (1.42b) to EBITDA (239.9m) ratio: 5.94 <= 3.0 (WARN <= 3.5)
Current Ratio 0.28 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (102.5m) change vs 12m ago 0.89% (target <= -2.0% for YES)
Gross Margin 59.66% (prev 58.79%; Δ 0.87pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 9.84% (prev 9.00%; Δ 0.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.65 (EBITDA TTM 239.9m / Interest Expense TTM 93.1m) >= 6 (WARN >= 3)

Altman Z'' -2.46

(A) -0.03 = (Total Current Assets 30.0m - Total Current Liabilities 108.1m) / Total Assets 2.79b
(B) -0.51 = Retained Earnings (Balance) -1.41b / Total Assets 2.79b
(C) 0.05 = EBIT TTM 153.9m / Avg Total Assets 2.90b
(D) -0.94 = Book Value of Equity -1.41b / Total Liabilities 1.51b
Total Rating: -2.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 52.70

1. Piotroski 2.0pt
2. FCF Yield 1.72%
3. FCF Margin 18.14%
4. Debt/Equity 1.24
5. Debt/Ebitda 5.94
6. ROIC - WACC (= 0.70)%
7. RoE 5.70%
8. Rev. Trend -31.60%
9. EPS Trend 40.73%

What is the price of VRE shares?

As of December 14, 2025, the stock is trading at USD 14.73 with a total of 362,633 shares traded.
Over the past week, the price has changed by +3.15%, over one month by -1.47%, over three months by -6.86% and over the past year by -14.49%.

Is VRE a buy, sell or hold?

Veris Residential has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold VRE.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the VRE price?

Issuer Target Up/Down from current
Wallstreet Target Price 17.8 20.5%
Analysts Target Price 17.8 20.5%
ValueRay Target Price 14.8 0.1%

VRE Fundamental Data Overview December 11, 2025

Market Cap USD = 1.58b (1.58b USD * 1.0 USD.USD)
P/E Trailing = 22.6508
P/S = 5.4203
P/B = 1.1524
Beta = 1.229
Revenue TTM = 285.2m USD
EBIT TTM = 153.9m USD
EBITDA TTM = 239.9m USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 31.0m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.42b USD (from netDebt column, last quarter)
Enterprise Value = 3.00b USD (1.58b + Debt 1.43b - CCE 8.78m)
Interest Coverage Ratio = 1.65 (Ebit TTM 153.9m / Interest Expense TTM 93.1m)
FCF Yield = 1.72% (FCF TTM 51.7m / Enterprise Value 3.00b)
FCF Margin = 18.14% (FCF TTM 51.7m / Revenue TTM 285.2m)
Net Margin = 22.09% (Net Income TTM 63.0m / Revenue TTM 285.2m)
Gross Margin = 59.66% ((Revenue TTM 285.2m - Cost of Revenue TTM 115.0m) / Revenue TTM)
Gross Margin QoQ = 59.72% (prev 61.56%)
Tobins Q-Ratio = 1.08 (Enterprise Value 3.00b / Total Assets 2.79b)
Interest Expense / Debt = 1.55% (Interest Expense 22.2m / Debt 1.43b)
Taxrate = 0.05% (35.0k / 77.6m)
NOPAT = 153.8m (EBIT 153.9m * (1 - 0.05%))
Current Ratio = 0.28 (Total Current Assets 30.0m / Total Current Liabilities 108.1m)
Debt / Equity = 1.24 (Debt 1.43b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 5.94 (Net Debt 1.42b / EBITDA 239.9m)
Debt / FCF = 27.54 (Net Debt 1.42b / FCF TTM 51.7m)
Total Stockholder Equity = 1.11b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.26% (Net Income 63.0m / Total Assets 2.79b)
RoE = 5.70% (Net Income TTM 63.0m / Total Stockholder Equity 1.11b)
RoCE = 6.14% (EBIT 153.9m / Capital Employed (Equity 1.11b + L.T.Debt 1.40b))
RoIC = 5.60% (NOPAT 153.8m / Invested Capital 2.75b)
WACC = 4.90% (E(1.58b)/V(3.01b) * Re(7.94%) + D(1.43b)/V(3.01b) * Rd(1.55%) * (1-Tc(0.00)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 5.41%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈51.1m ; Y1≈33.5m ; Y5≈15.3m
Fair Price DCF = 3.23 (DCF Value 301.4m / Shares Outstanding 93.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 40.73 | EPS CAGR: 26.32% | SUE: 4.0 | # QB: 2
Revenue Correlation: -31.60 | Revenue CAGR: -4.78% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.11 | Chg30d=-0.060 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.23 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=-134.1% | Growth Revenue=-1.2%

Additional Sources for VRE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle